# Clinical Effects of Temperature Controlled Laminar Airflow (TLA)

> **NCT00987064** · PHASE2 · COMPLETED · sponsor: **Airsonett AB** · enrollment: 28 (actual)

## Conditions studied

- Asthma
- Perennial Allergy

## Interventions

- **DEVICE:** Temperature controlled Laminar Airflow (Protexo)
- **DEVICE:** Placebo TLA

## Key facts

- **NCT ID:** NCT00987064
- **Lead sponsor:** Airsonett AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-05
- **Final completion:** 2006-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-01-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987064, "Clinical Effects of Temperature Controlled Laminar Airflow (TLA)". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00987064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*